Global Pharma 4 is in the making. Launching 2026.
Not a course.
A mindset shift for those shaping the future of pharma.
From Molecule to Market → The Silent Wars Behind Every Molecule
Global Trends → The Rules Are Being Rewritten
Commercial Strategy → What They Don’t Teach at Business School
Leadership → Power, Bias & the Human Factor
Be considered for the 4th edition.
Seats are highly limited.
Every application is reviewed individually by the GenH team.
We select people who will elevate the conversation.
This is a
Learn & Act Course
Our Learn & Act model combines expert-led learning with hands-on application. Participants first gain advanced insights and skills, then collaborate to tackle a real-world business case from an actual company.
André de Aragão Azevedo
Member of the
ESNA Advisory Board
Teresa Guerreiro
Market Access, Pricing & HTA
Senior Consultant
Hugo Barbosa
EU Customer Omnichannel Director
at ViiV Healthcare
Tarkan Dogru
Head Technical Development Synthetic Molecules at Roche
Sofia Ferreira
Managing Director at
Organon Portugal
André Correia
Executive VP at SERaro.pt
Hélder Romão
Partner at DSR + Head of Marketing & Creativity at GenH
Daniel Guedelha
Founder & CEO at GenH
João Santos Pereira
Executive Director at Católica Medical School
Ana Rita Constante
Executive Director at CAC-CL
Top Leaders
Filipa Mota e Costa
Managing Director at J&J Innovative Medicine Portugal
Paulo Teixeira
Country Manager at Pfizer Portugal
Paula Rosa
Senior Director Product
Strategy at Roche
Paulo Barradas Rebelo
President at Bluepharma
Paula Martins de Jesus
Medical Director at MSD
Sérgio Alves
Global Head of Health Equity at AstraZeneca
The Faculty and Católica staff
Nina Fernandes
Medical Advisor Oncology at MSD Portugal
Knowledge partners
After the course, you’re not done.
You’re part of the Global Pharma network.
The people who’ve joined this program now work across
Pfizer, Novartis, Roche, Sanofi, Johnson & Johnson, AbbVie and beyond.
They’ve taken what they learned here and:
• Changed teams and roles
• Rebuilt strategies
• Got promoted
• Or simply found clarity on what they want next
You don’t just gain insights.
You gain access.
To a growing network of alumni that actually opens doors — and answers your messages.
-
As this course is designed for extensive interaction with the Professors and the students, it requires physical presence.
-
The course will start in March 2025 and take place every week on: Fridays (starting 17h00) and Saturdays (09h00-13h00).
-
Most of the sessions will be in Portuguese. There may be sessions in English, as we will also have international speakers.
-
Yes. A participation diploma will be provided at the end of the course and if the students comply with the needed requirements.
-
Yes. You do not need to be sponsored by your company to undertake this course.
-
Yes. The course is exactly designed to have lots of interactions with the senior leaders that will give the lectures.
-
No. This course was not designed to provide theoretical but mostly practical information.
-
This is a short course and not a post graduation.
“This course encourages innovation and entrepreneurship in the health sector, offering fundamental tools for any role in the Pharmaceutical Industry.”
Margarida Gaião,
Medical Science Liaison
Radioligand Therapies
at Novartis Portugal
GP1 Participant
“This course was a milestone in acquiring the most current knowledge about the Pharmaceutical Industry in Portugal and the world”
Rui Pardelha,
Territory Manager Middle East , Turkye and Africa
GP1 Participant
"Participating in this course was an incredible experience, where a diversity of colleagues from different areas inspires us to explore curiosity and creativity, to think innovatively and build solutions for better access to healthcare for our patients"
Susana Moreira,
Regulatory Affairs Manager
Spain & Portugal at Sandoz Iberia
GP2 Participant
